Search

U.S. patent #11,130,743 has been granted

cjdocken
Sep 28, 2021
1 min read

The patent (Heterocyclic ligands of PAR1 and methods of use) includes Chris Dockendorff and Marquette University graduate students Disha Gandhi and Ricardo Rosas, Jr. as inventors.

Recent Posts

See All

Function Therapeutics receives SBIR award to study potential treatment for liver disease (MASH)

Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...

Parmodulin shows beneficial effects in obese mice

In the Journal of Thrombosis and Haemostasis, the lab of Dr. James Luyendyk (Michigan State University) and colleagues reported the...

Function Therapeutics receives SBIR award to study acute kidney injury (AKI)

Function Therapeutics has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Institute of Diabetes...

FOR NEWS INQUIRIES

Contact Us